Shasqi

Shasqi company information, Employees & Contact Information

Explore related pages

Related company profiles:

Shasqi is a biotech company whose mission is to revolutionize cancer treatment with click chemistry, a 2022 Nobel Prize winning technology. Our unique CAPAC® (Click Activated Protodrugs Against Cancer) platform uses click chemistry to target high doses of cancer drugs directly to the site of the tumor while minimizing toxicity to healthy cells, potentially improving the therapeutic index. Shasqi has developed an expansive and diverse library of antibody-mediated tumor-targeting agents and cancer therapeutic payloads. These are decoupled from each other and reunited at the site of the tumor via a click chemistry reaction. We are the first company to use click chemistry in humans. For more information, visit us at www.shasqi.com

Company Details

Employees
29
Founded
-
Address
San Francisco, California 94107, Us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
San Francisco, California
Looking for a particular Shasqi employee's phone or email?

Shasqi Questions

News

Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies - PR Newswire

Shasqi Publishes Landmark Study in Clinical Cancer Research: First-in-Human Use of Click Chemistry Unlocks New Opportunities for Targeted Cancer Therapies PR Newswire

SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY - PR Newswire

SHASQI STRENGTHENS BOARD OF DIRECTORS WITH THE APPOINTMENT OF FORMER CHIEF DEVELOPMENT OFFICER AT PFIZER ONCOLOGY PR Newswire

Shasqi's click chemistry platform shows complete tumor regression - drugdiscoverytrends.com

Shasqi's click chemistry platform shows complete tumor regression drugdiscoverytrends.com

Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents - ACS Publications

Click Chemistry Selectively Activates an Auristatin Protodrug with either Intratumoral or Systemic Tumor-Targeting Agents ACS Publications

Shasqi snatches $50M for chemotherapy-boosting treatments thanks to Arcus, NGM execs - Fierce Biotech

Shasqi snatches $50M for chemotherapy-boosting treatments thanks to Arcus, NGM execs Fierce Biotech

Shasqi using click chemistry to target cancer - Labiotech.eu

Shasqi using click chemistry to target cancer Labiotech.eu

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non‐Injected Lesions - Srinivasan - 2021 - Advanced Therapeutics - Wiley Online Library

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non‐Injected Lesions - Srinivasan - 2021 - Advanced Therapeutics Wiley Online Library

Nobel laureate takes pride in success of bioorthogonal chemistry for cancer treatment - Healio

Nobel laureate takes pride in success of bioorthogonal chemistry for cancer treatment Healio

A deep dive on Shasqi and J&J click chemistry alliance - drugdiscoverytrends.com

A deep dive on Shasqi and J&J click chemistry alliance drugdiscoverytrends.com

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non-Injected Lesions - Wiley

SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non-Injected Lesions Wiley

Shasqi deepens CAPAC pact with Johnson & Johnson - drugdiscoverytrends.com

Shasqi deepens CAPAC pact with Johnson & Johnson drugdiscoverytrends.com

Top Shasqi Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant